Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP205545.RAiPM3qu4Q7YrmL402sMnuos81r843Xj071NKvbHj7WDg130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP205545.RAiPM3qu4Q7YrmL402sMnuos81r843Xj071NKvbHj7WDg130_provenance.
• NP722218.RAut2SAvDHxdOmHGsbPQnQlem3FOEkf1IbLaQ0gbX5sxk130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722218.RAut2SAvDHxdOmHGsbPQnQlem3FOEkf1IbLaQ0gbX5sxk130_provenance.
• NP285262.RAMND7uSG_qFu3rULH867l563u7gIA_wLgDKaNTVWgwMA130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285262.RAMND7uSG_qFu3rULH867l563u7gIA_wLgDKaNTVWgwMA130_provenance.
• NP651931.RAyq5LkgEt-NWkSkAzCSyp1zK4aQx651fHRqVspHY3zfg130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651931.RAyq5LkgEt-NWkSkAzCSyp1zK4aQx651fHRqVspHY3zfg130_provenance.
• NP643519.RAE2BVEULrhJyObJe_2YQ1H2M5O3Yl4aoJB-uyULuIOu0130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643519.RAE2BVEULrhJyObJe_2YQ1H2M5O3Yl4aoJB-uyULuIOu0130_provenance.
• assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP700970.RAMI6pWVOYT-fLlEcZqy_Tw7LoOZnJD26PE9bKl1Qfo3o130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700970.RAMI6pWVOYT-fLlEcZqy_Tw7LoOZnJD26PE9bKl1Qfo3o130_provenance.
• NP495427.RABulgVeHJEfQBaj088qEcFccOgBHYLt8q_beaHLHCLpM130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495427.RABulgVeHJEfQBaj088qEcFccOgBHYLt8q_beaHLHCLpM130_provenance.
• NP495432.RAUW1JMN7FFCcLH1nSdMxGpcgkOkT7iwSIRtIO7pO5hcI130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495432.RAUW1JMN7FFCcLH1nSdMxGpcgkOkT7iwSIRtIO7pO5hcI130_provenance.
• NP495424.RAi91qhtj2neYLZqErp6a9zo7kdJlhBk3xtsygKhyNAh8130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495424.RAi91qhtj2neYLZqErp6a9zo7kdJlhBk3xtsygKhyNAh8130_provenance.
• NP495425.RAo3sQQaxjxKODS3g9UoefIA1WDyrmxrgqB-IbvX5aWmc130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495425.RAo3sQQaxjxKODS3g9UoefIA1WDyrmxrgqB-IbvX5aWmc130_provenance.
• NP495429.RAhPgPuldaYSH6XcwpCXYawwZBd7SBrBv6jHhn8lC4stI130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495429.RAhPgPuldaYSH6XcwpCXYawwZBd7SBrBv6jHhn8lC4stI130_provenance.
• NP495428.RAIMGrDc6ju-QpfdNB3SiOobhWq3GCSPy1960byGC7fOc130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495428.RAIMGrDc6ju-QpfdNB3SiOobhWq3GCSPy1960byGC7fOc130_provenance.
• NP495426.RA7vwgoGjkfOZNWKlXM6qwB9SHWSefWnS5ks4E1HrumeY130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495426.RA7vwgoGjkfOZNWKlXM6qwB9SHWSefWnS5ks4E1HrumeY130_provenance.
• NP495434.RA0fOnWSORExHumai6JdXg844F7iaYRbc7pxrOmGGwHYs130_assertion description "[We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495434.RA0fOnWSORExHumai6JdXg844F7iaYRbc7pxrOmGGwHYs130_provenance.